A detailed history of Jane Street Group, LLC transactions in Certara, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 147,393 shares of CERT stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147,393
Previous 143,661 2.6%
Holding current value
$1.58 Million
Previous $1.99 Million 13.27%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.46 - $16.58 $39,036 - $61,876
3,732 Added 2.6%
147,393 $1.73 Million
Q2 2024

Aug 14, 2024

BUY
$13.36 - $18.94 $120,253 - $170,478
9,001 Added 6.68%
143,661 $1.99 Million
Q1 2024

May 15, 2024

BUY
$15.65 - $19.45 $545,668 - $678,163
34,867 Added 34.94%
134,660 $2.41 Million
Q4 2023

Feb 14, 2024

BUY
$12.12 - $18.19 $1.21 Million - $1.82 Million
99,793 New
99,793 $1.76 Million
Q2 2023

Aug 14, 2023

BUY
$16.89 - $24.64 $242,489 - $353,756
14,357 New
14,357 $261,000
Q3 2022

Nov 14, 2022

SELL
$12.84 - $24.13 $2.31 Million - $4.33 Million
-179,570 Reduced 88.91%
22,394 $297,000
Q2 2022

Aug 16, 2022

BUY
$16.75 - $22.54 $2.84 Million - $3.82 Million
169,594 Added 523.92%
201,964 $4.33 Million
Q1 2022

May 17, 2022

BUY
$17.89 - $28.73 $400,968 - $643,925
22,413 Added 225.1%
32,370 $695,000
Q4 2021

Feb 15, 2022

SELL
$26.1 - $45.21 $2.29 Million - $3.97 Million
-87,838 Reduced 89.82%
9,957 $283,000
Q3 2021

Nov 16, 2021

BUY
$24.46 - $38.41 $2.15 Million - $3.38 Million
87,878 Added 886.13%
97,795 $3.24 Million
Q2 2021

Aug 16, 2021

SELL
$24.79 - $33.31 $2.22 Million - $2.99 Million
-89,666 Reduced 90.04%
9,917 $281,000
Q4 2020

Feb 17, 2021

BUY
$33.59 - $40.18 $3.34 Million - $4 Million
99,583 New
99,583 $3.36 Million

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.71B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.